HSE reimburses Braftovi combo
admin 23rd August 2019 Uncategorised 0Eligible patients in the Republic of Ireland can potentially benefit from the combination with immediate effect. More: HSE reimburses Braftovi combo Source: News
read more
Eligible patients in the Republic of Ireland can potentially benefit from the combination with immediate effect. More: HSE reimburses Braftovi combo Source: News
read moreThe lack of immunisation leaves children at high risk of measles at a time when outbreaks of the disease are occurring across the country. More: One in seven five-year-olds don’t have MMR jabs Source: News
read moreImagine HIV patients needed to take their antiretroviral therapies not every day, not even every month, but every two months. A GlaxoSmithKline two-drug injectable regimen that’s already under review by the FDA for monthly use could soon turn it into
read morePfizer and Astellas are chasing a new nod for prostate cancer drug Xtandi, and thanks to a new move from the FDA, they might not have to wait that long. Wednesday, the agency bestowed priority review on their application for
read moreEarlier this month, amid a deadly dengue outbreak, it looked as if the Philippines might start using Sanofi’s Dengvaxia again. But that’s off the table because Sanofi failed to live up to its post-marketing commitments, health officials there said this
read moreFibroGen has not even filed its AstraZeneca-partnered oral anemia drug roxadustat for U.S. regulatory approval. But now, with a second nod in China, the blockbuster hopeful is allowed to treat all chronic kidney disease patients with anemia, regardless of whether
read more© 1994 - 2026 B.M. Pharmaceuticals